One of the hottest new offerings of 2020 has been Palantir Technologies (NASDAQ: PLTR), with shares up nearly 200% since its IPO. What Happened: Palantir's stock surged Monday following a Bloomberg report of the company landing a three-year, $44-million contract with the U.S. Food and Drug Administration.
Palantir Shares Surge On Report Of $44M FDA Contract